Frederick W Thielen, Rosanne Diepeveen, Franciska de Beer, Marieke Begemann, Nynke Boonstra, Lieuwe de Haan, Sinan Guloksuz, Shiral Gangadin, Martijn Kikkert, Sanne Koops, Jim van Os, Nico van Beveren, Wim Veling, Bram-Sieben Rosema, Hamlett-Ophelia Consortium, Iris E Sommer, Ben Wijnen
{"title":"Cost-Effectiveness of Early Dose Reduction or Discontinuation Versus Antipsychotic Maintenance After First-Episode Psychosis: Results From the HAMLETT Study.","authors":"Frederick W Thielen, Rosanne Diepeveen, Franciska de Beer, Marieke Begemann, Nynke Boonstra, Lieuwe de Haan, Sinan Guloksuz, Shiral Gangadin, Martijn Kikkert, Sanne Koops, Jim van Os, Nico van Beveren, Wim Veling, Bram-Sieben Rosema, Hamlett-Ophelia Consortium, Iris E Sommer, Ben Wijnen","doi":"10.1111/acps.70152","DOIUrl":"https://doi.org/10.1111/acps.70152","url":null,"abstract":"<p><strong>Background: </strong>After remission from a first episode psychosis (FEP), international clinical guidelines recommend continuation of antipsychotic medication for at least 1 year, although many patients wish to reduce or discontinue medication due to side effects or long-term health concerns. Evidence on the cost-effectiveness of early dose reduction or discontinuation compared to continuation remains limited.</p><p><strong>Methods: </strong>A trial-based cost-utility analysis was conducted alongside the ongoing HAMLETT study, in which 347 remitted FEP participants were randomized to either early guided dose reduction or discontinuation or maintenance treatment for 1 year. Both healthcare and societal perspectives over a 24-month time horizon were considered. Health outcomes were expressed as quality-adjusted life years (QALYs) derived from the EQ-5D-5L questionnaire using Dutch valuation tariffs. Costs were estimated using patient reported healthcare utilization and administrative pharmacy data. Incremental costs and effects were analysed using seemingly unrelated regression with uncertainty assessed through nonparametric bootstrapping and multiple sensitivity analyses.</p><p><strong>Results: </strong>Early dose reduction or discontinuation was associated with lower quality-adjusted life years and higher or comparable costs compared with maintenance treatment over the 2-year analysis period. In the base-case societal perspective analysis, incremental costs were €23,563 and incremental effects were -0.077 QALYs, resulting in an incremental net monetary benefit of -€27,430 at a willingness-to-pay threshold of €50,000 per QALY at 24 months. Results were consistent across several scenarios with only approximately 9% probability that early dose reduction or discontinuation was cost-effective at the assumed willingness-to-pay threshold. However, a sex-at-birth subgroup analysis suggested a small and uncertain positive incremental net monetary benefit among female participants.</p><p><strong>Conclusion: </strong>Over a 24-month period, early dose reduction or discontinuation of antipsychotic medication after remission from a FEP is unlikely to be cost-effective compared with maintenance treatment from both healthcare and societal perspectives. Whether longer term functional improvements associated with early dose reduction translate into cost-effective benefits remains uncertain and requires follow-up.</p><p><strong>Trial registration: </strong>EudraCT number: 2017-002406-12.</p>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149331748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Reevaluating the Role of ADHD Perceptions in Medication Continuation: Methodological and Interpretative Considerations","authors":"Yingjie Gao, Cong Zhou, Sen Li","doi":"10.1111/acps.70125","DOIUrl":"10.1111/acps.70125","url":null,"abstract":"","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"154 6","pages":"461-462"},"PeriodicalIF":4.7,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148395418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Meng-Chiao Chou, Po-Yu Chen, Yueh-Pin Lin, Win-Yin Chen, Sheng-Siang Su, Shang-Ying Tsai, Chiao-Chicy Chen, Chian-Jue Kuo
{"title":"Age-Stratified Patterns of Suicide Methods in Bipolar Disorder: A Nationwide Cohort Study","authors":"Meng-Chiao Chou, Po-Yu Chen, Yueh-Pin Lin, Win-Yin Chen, Sheng-Siang Su, Shang-Ying Tsai, Chiao-Chicy Chen, Chian-Jue Kuo","doi":"10.1111/acps.70132","DOIUrl":"10.1111/acps.70132","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>Age-stratified suicide methods in bipolar disorder remain underexplored. This study compared method selection between suicide decedents with bipolar disorder and the general population.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We identified 47,488 individuals with bipolar disorder between 2003 and 2023 from Taiwan's nationwide health database and linked mortality records to ascertain suicide deaths. Using a decedent-only design, we compared the distribution of suicide methods between suicide decedents with bipolar disorder and those from the general population. Age-stratified (< 30, 30–49, 50–64, and ≥ 65 years) multivariable logistic regression analyses were performed with adjustment for sex, age at death, urbanization level, and employment status.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 1452 suicide deaths over 478,729 person-years (incidence: 303.3 per 100,000), the most common methods were hanging (28.0%), charcoal burning and other gas poisoning (20.9%), jumping from a high place (18.0%), drug overdose (16.9%), and drowning (11.4%). Suicide decedents in the bipolar cohort had higher odds of drowning (adjusted odds ratio [aOR]: 1.70, 95% confidence interval [CI]: 1.44–2.00) and jumping from a high place (aOR: 1.31, 95% CI: 1.14–1.50) but lower odds of charcoal burning and other gas poisoning (aOR: 0.69, 95% CI: 0.60–0.79) and hanging (aOR: 0.87, 95% CI: 0.77–0.98) than did general-population decedents (<i>n</i> = 81,159). Age-stratified analyses showed charcoal burning concentrated in younger and middle-aged decedents, drowning consistently elevated across age strata, and jumping elevated in middle-aged and older decedents.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Individuals with bipolar disorder who die by suicide exhibit distinct, age-dependent patterns of suicide methods. Therefore, prevention strategies should be tailored to both age groups and methods.</p>\u0000 </section>\u0000 </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"154 6","pages":"428-438"},"PeriodicalIF":4.7,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148676329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Philipp Wülfing, Carsten Spitzer, Judy Leibowitz, Stephen Pilling, Peter Fonagy, P. Read Montague, Tobias Nolte
{"title":"Associations Between Dissociation and Childhood Trauma in Borderline Personality Disorder and Affective Disorders: A Network Analytic Approach","authors":"Philipp Wülfing, Carsten Spitzer, Judy Leibowitz, Stephen Pilling, Peter Fonagy, P. Read Montague, Tobias Nolte","doi":"10.1111/acps.70131","DOIUrl":"10.1111/acps.70131","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Dissociation and childhood trauma are strongly associated with borderline personality disorder (BPD), yet it remains unclear whether this reflects disorder-specific mechanisms or differences in symptom severity within a shared transdiagnostic structure.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Using network analysis, we examined whether the conditional dependency architecture linking childhood trauma, dissociation, posttraumatic stress symptoms, and general psychological distress differs between individuals diagnosed with BPD and affective disorders (AD).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Participants were drawn from a large outpatient clinical sample and matched on age, gender, and global symptom severity (BSI-GSI). Networks were estimated using regularized partial correlation models including CTQ subscales, DES subscales, PTSD symptom clusters, and overall distress. Network Comparison Tests assessed structural invariance and global strength differences between diagnostic groups.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>As expected, individuals with BPD reported significantly higher levels of childhood trauma and dissociation than those with AD. However, despite these marked differences in severity, the overall network structure did not significantly differ between groups, and global connectivity was comparable. Bridge centrality analyses indicated similar patterns of interconnection across trauma, dissociation, and PTSD domains in both diagnoses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>These findings suggest that BPD is characterized by elevated severity within a largely shared trauma–dissociation architecture, rather than by a qualitatively distinct network configuration. The results support a transdiagnostic model in which childhood trauma and dissociative processes are embedded within a common psychopathological structure, with diagnostic distinctions reflecting differences in magnitude rather than rewiring of interrelations. This severity–versus–architecture distinction has implications for understanding mechanisms of vulnerability and for targeting shared pathways across diagnostic categories.</p>\u0000 </section>\u0000 </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"154 6","pages":"418-427"},"PeriodicalIF":4.7,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/acps.70131","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148700306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Risk-Stratified Cardiac Monitoring During Antipsychotic Treatment in Adolescents and Young Adults","authors":"Alessandro Cuomo, Mario Pinzi, Andrea Fagiolini","doi":"10.1111/acps.70146","DOIUrl":"10.1111/acps.70146","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Antipsychotic-associated heart rate-corrected QT (QTc) prolongation and sudden cardiac death are uncommon in young people, but risk is concentrated in patients with identifiable clinical vulnerability and during selected drug- or exposure-related situations. We mapped the evidence and developed a risk-stratified framework for clinical monitoring.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This structured narrative review searched PubMed in August 2026 using one comprehensive query and 41 targeted subqueries. After PMID-based deduplication, 934 unique records underwent title screening, 382 abstract review, and 158 full-text relevance assessment; 104 database-derived sources met broad relevance criteria. Backward citation checking and author-identified sources added 58 articles. Overall, 162 sources were considered and 100 providing direct, non-redundant support were cited from the original search; three further sources were incorporated during peer review to address reviewer comments, for a final total of 103 cited references. Two authors independently assessed full-text relevance. Youth evidence was prioritized; adult evidence was used for adult-only agents or when youth-specific data were unavailable. Findings were synthesized narratively without formal risk-of-bias or certainty assessment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Patient-level factors, particularly electrolyte disturbance, bradycardia, restrictive eating disorder or medical instability, thyroid dysfunction, inherited channelopathy, structural disease, and interacting drugs, were more consistently associated with QTc risk than drug identity for many commonly used agents. Ziprasidone and pimozide had the strongest youth-specific drug-related signals. Adult evidence supported heightened caution with sertindole and iloperidone; high-dose phenothiazines and amisulpride in overdose or renal impairment represented exposure- or context-dependent risks. Clozapine required separate myocarditis-focused surveillance. The evidence supports structured baseline risk assessment and targeted ECG and electrolyte testing, with repeat monitoring driven by risk factors, treatment changes, and agent-specific warnings.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Monitoring should be tiered rather than uniformly scheduled for all patients. The proposed framework distinguishes core clinical risk assessment from targeted cardiac testing and identifies precautionary intervals that require prospective validation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"154 6","pages":"439-456"},"PeriodicalIF":4.7,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149101376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Thomas C. Feenstra, Natascha den Bleijker, Adriaan W. Hoogendoorn, Huda Gafer, Nathalie Denayer, Eric van Exel, Rob M. Kok, Karina Somers, Anton C. M. Vergouwen, Adriano van der Loo, Esmée Verwijk, Filip Bouckaert, Aartjan T. F. Beekman, Pascal Sienaert, Didi Rhebergen
{"title":"Prognostic Factors for Postictal Agitation After Electroconvulsive Therapy in Older Adults With Depression","authors":"Thomas C. Feenstra, Natascha den Bleijker, Adriaan W. Hoogendoorn, Huda Gafer, Nathalie Denayer, Eric van Exel, Rob M. Kok, Karina Somers, Anton C. M. Vergouwen, Adriano van der Loo, Esmée Verwijk, Filip Bouckaert, Aartjan T. F. Beekman, Pascal Sienaert, Didi Rhebergen","doi":"10.1111/acps.70128","DOIUrl":"10.1111/acps.70128","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>\u0000 <span>Postictal agitation (PIA) is an impactful confusional state occasionally occurring after electroconvulsive therapy (ECT). PIA creates dangerous situations for caregivers and patients, prolongs lead times, and sometimes leads to the premature discontinuation of ECT. Despite the impact PIA can have on patients and caregivers, little is known about its incidence and the factors associated with its occurrence. This study aims to investigate putative prognostic factors for PIA.</span>\u0000 </p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p><span>We utilized data from the “Rivastigmine for ECT-induced Cognitive Adverse effects in Late-Life depression” (RECALL) prospective cohort study; a study on older adults (</span>≥ <span>55 years) with a major depressive episode receiving ECT. We investigated several putative prognostic factors based on previous research, biological plausibility, and availability. PIA was defined by either a Richmond Agitation-Sedation score</span> ≥ <span>2 or the administration of emergency medication specifically for PIA. Mixed-effects logistic regression was used to analyze univariate and adjusted odds ratios for the prognostic factors.</span></p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>\u0000 <span>We included 142 patients who received 1838 ECT sessions. The incidence of PIA was 34.5% at the patient-level and 9.2% at the session-level. A small subset of older adults (19.7%) accounted for 87.5% of all PIA occurrences. We found that male sex, flumazenil use, and a longer seizure duration were associated with higher odds of developing PIA. Multi-seizure sessions and a higher level of education were associated with lower occurrence of PIA.</span>\u0000 </p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>\u0000 <span>This study identified sex, flumazenil use, seizure duration, the amount of seizures during a session, and education level as prognostic factors for PIA. The pronounced clustering of PIA events within a small subset of patients suggests meaningful interindividual vulnerability, but should be replicated in future studies. If confirmed, these findings could provide actionable insights for preventive treatment strategies. In particular, the use of flumazenil should be critically reconsidered in persons experiencing PIA.</span>\u0000 </p>\u0000 \u0000 <p>\u0000 <span><b>Trial Registration:</b> EudraCT 2014-003385-24.</span>\u0000 </p>\u0000 </section>\u0000 </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"154 6","pages":"399-407"},"PeriodicalIF":4.7,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148454103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stanley Lyndon, Jason B. Gibbons, Loreen Straub, Meekang Sung, Jacob C. Jameson, David B. Hathaway, Denise H. Mulcahy, Cason Elliott, Rachel Wood, Matthew Ruble, Alejandro G. Szmulewicz, Jie Yang, Rajendra Aldis, Richard Wyss, Philip S. Wang, Shan H. Siddiqi
{"title":"Transcranial Magnetic Stimulation Retreatment for Recurrent Depression: A Large Real-World Multisite Cohort Study","authors":"Stanley Lyndon, Jason B. Gibbons, Loreen Straub, Meekang Sung, Jacob C. Jameson, David B. Hathaway, Denise H. Mulcahy, Cason Elliott, Rachel Wood, Matthew Ruble, Alejandro G. Szmulewicz, Jie Yang, Rajendra Aldis, Richard Wyss, Philip S. Wang, Shan H. Siddiqi","doi":"10.1111/acps.70130","DOIUrl":"10.1111/acps.70130","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>When depressive symptoms return after an initial response to transcranial magnetic stimulation (TMS), evidence to guide use of a second acute course is strikingly limited. We aimed <b>t</b>o estimate how often and how quickly patients with recurrent major depressive disorder benefit from a second course of transcranial magnetic stimulation after they previously improved with TMS.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A retrospective cohort study across 20 outpatient centres included 259 patients who received ≥ 2 TMS courses between January 1, 2023 and October 1, 2025, and had clinically significant depressive symptoms at the start of course 2; 177 prior responders formed the primary cohort. Treatment used standard 10-Hz left dorsolateral prefrontal cortex TMS. Response and remission were assessed using the PHQ-9 and/or BDI-II; response was defined as a ≥ 50% reduction and remission as PHQ-9 ≤ 4 and/or BDI-II ≤ 9. Symptom change from baseline to end of course 2 and time to first response by session were compared between courses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among past responders, 146 of 177 patients (82.5%; 95% CI, 76.1%–87.8%) responded again during course 2 and 96 of 177 (54.2%; 95% CI, 46.6%–61.7%) achieved remission. PHQ-9 scores decreased by a median of 65.0% (<i>p</i> < 0.001), and BDI-II scores decreased by a mean of 12.0 points (95% CI, −14.0 to −10.0; <i>p</i> < 0.001). Among responders, the first session meeting response criteria occurred earlier during retreatment than during the initial course on both PHQ-9 (median session, 12 vs. 16; hazard ratio = 1.40, 95% CI, 1.14–1.72; <i>p</i> = 0.001) and BDI-II (13.5 vs. 22.5; hazard ratio = 1.46, 95% CI, 1.07–2.00; <i>p</i> = 0.018).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Most patients who previously benefited from acute TMS improved again when symptoms recurred, and among responders, the first session meeting response criteria often occurred earlier during retreatment than during the initial course.</p>\u0000 </section>\u0000 </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"154 6","pages":"408-417"},"PeriodicalIF":4.7,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148628917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alexander Sartorius, Charles H. Kellner, Randall T. Espinoza
{"title":"Side Effects of Electroconvulsive Therapy (ECT)","authors":"Alexander Sartorius, Charles H. Kellner, Randall T. Espinoza","doi":"10.1111/acps.70147","DOIUrl":"10.1111/acps.70147","url":null,"abstract":"<p>One of the most important components of informed consent in medicine is the presentation of the risks and benefits of a planned treatment. A side effect is an actual but secondary and unintended effect that occurs as the result of the primary action of a treatment, while a risk is the probability and severity of potential harm occurring. Typically, two aspects should be given particular emphasis: the most severe and the most frequent adverse effects. With regard to electroconvulsive therapy (ECT), these domains can be conceptualized as safety and tolerability, with the principal concerns being mortality and cognitive adverse effects. This editorial will therefore focus on these two aspects.</p><p>Regarding the risks and side effects of ECT, two central aspects merit particular attention: safety and tolerability, with mortality and cognitive side effects being the primary considerations. Mortality associated with modern ECT is extremely rare and substantially lower than established routine surgical procedures. Moreover, withholding an indicated course of ECT is associated with an increased risk of suicide and all-cause mortality.</p><p>Cognitive side effects, by contrast, are common but are almost invariably transient. Following a course of ECT, most cognitive impairments resolve within 2–4 weeks, and several cognitive functions actually may improve beyond pretreatment levels. With regard to the extent of longer-term impairment of episodic autobiographical memory, the evidence remains inconclusive because of substantial methodological heterogeneity and numerous potential confounding factors, including the underlying disorder itself, patient characteristics and premorbid functioning, concomitant medication, treatment-related factors like electrode placement and stimulation parameters, and effects of anesthesia.</p><p>The authors have nothing to report.</p><p>Dr. C.H.K. reports royalties from Cambridge University Press for “Handbook of ECT” (2019), fees from UpToDate for writing/editing ECT topics, fees from Northwell Health for teaching in an ECT course, and fees for serving as an ECT expert in legal cases. Dr R.T.E. reports funding support from NIMH, the Garvey Endowed Professorship for Brain Health and Technology, UptoDate Inc., and Wolters Kluwer Publishing. The authors have no conflicts of interest or financial disclosures to report.</p><p>Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.</p>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"154 6","pages":"395-398"},"PeriodicalIF":4.7,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/acps.70147","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149101359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Patients Receiving 100 or More Electroconvulsive Therapy Treatments in a Nationwide Cohort","authors":"Masahiro Hata, Yuki Miyazaki, Shun Takahashi","doi":"10.1111/acps.70137","DOIUrl":"10.1111/acps.70137","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Very high cumulative exposure to electroconvulsive therapy (ECT) has primarily been described in individual case reports. We examined cumulative ECT exposure in a nationwide Japanese claims database to characterize patients receiving very high numbers of treatments.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We identified 3,733 patients who received ECT and classified them according to cumulative ECT exposure. Clinical characteristics of patients receiving 100 or more treatments were examined.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 3,733 patients who received ECT, 39 (1.0%) received 100 or more treatments. These patients had treatment durations of several years and substantially greater numbers of psychiatric hospitalizations and cumulative hospitalization days. Clozapine use increased across cumulative ECT exposure categories, although it was recorded in only 13% of patients receiving 100 or more treatments.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Patients receiving 100 or more ECT treatments represent an identifiable subgroup of ECT recipients characterized by prolonged and recurrent psychiatric care.</p>\u0000 </section>\u0000 </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"154 6","pages":"457-460"},"PeriodicalIF":4.7,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/acps.70137","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148816856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy of Non-Invasive Brain Stimulation on the Treatment of Late Life Depression: A Systematic Review and Network Meta-Analysis.","authors":"Chemin Lin, Wen-Yin Chen, Yu-Tsung Liu, Huang-Li Lin, Shwu-Hua Lee, Chen-Hsin Yu, Chih-Chiang Chiu, Chi-Ming Chiang, Pei-Tsen Chen, Ying-Chih Cheng","doi":"10.1111/acps.70144","DOIUrl":"https://doi.org/10.1111/acps.70144","url":null,"abstract":"<p><strong>Objective: </strong>This network meta-analysis (NMA) aimed to evaluate the comparative efficacy of non-invasive brain stimulation (NIBS) interventions for late-life depression (LLD), with treatment rankings provided as a secondary outcome.</p><p><strong>Methods: </strong>We conducted a systematic review and NMA of randomized controlled trials (RCTs) assessing NIBS for major depressive disorder in adults aged ≥ 60 years. Comprehensive searches of PubMed, EMBASE, and Cochrane Library were performed up to June 2025. Two reviewers independently selected studies, extracted data, and assessed quality using the Cochrane Risk of Bias tool. A random-effects NMA was implemented using the netmeta package in R. Certainty of evidence was evaluated using the GRADE framework. Primary outcomes included changes in depressive symptoms, measured by the standard mean difference (SMD). Secondary outcomes included response rates and remission rates.</p><p><strong>Results: </strong>Twenty-five RCTs involving 1344 participants and 15 NIBS modalities were included. Bilateral electroconvulsive therapy (BL-ECT; SMD = 1.13, 95% CI 0.37-1.90) and high-frequency repetitive transcranial magnetic stimulation over the left dorsolateral prefrontal cortex (rTMS-10Hz-F3; SMD = 0.42, 95% CI 0.02-0.81) consistently outperformed sham across all efficacy outcomes. Both interventions formed closed loops of the network geometry, enabling formal assessment of agreement between direct and indirect evidence. Although inconsistency was detected in the symptom severity network, both interventions demonstrated consistent benefits across efficacy outcomes and retained moderate-certainty evidence.</p><p><strong>Conclusion: </strong>BL-ECT and rTMS-10Hz-F3 emerged as the most consistently effective NIBS treatments for LLD, supported by moderate-certainty evidence. Other highly-ranked modalities require cautious interpretation due to sparse data.</p><p><strong>Registration: </strong>PROSPERO (CRD42024628560).</p>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149259671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}